Rhinovirus-associated wheezing and asthma in young children by Piotrowska, Zofia
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
6-3-2009
Rhinovirus-associated wheezing and asthma in
young children
Zofia Piotrowska
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Piotrowska, Zofia, "Rhinovirus-associated wheezing and asthma in young children" (2009). Yale Medicine Thesis Digital Library. 449.
http://elischolar.library.yale.edu/ymtdl/449
  
 
 
Rhinovirus-associated wheezing and asthma in young children 
 
 
 
 
 
 
 
A Thesis Submitted to the 
Yale University School of Medicine 
in Partial Fulfillment of the Requirements for the Joint 
Degree of Doctor of Medicine and Master of Health Science 
 
 
By 
 
Zofia Piotrowska 
2008 
 2
RHINOVIRUS-ASSOCIATED WHEEZING AND ASTHMA IN YOUNG CHILDREN 
 
Zofia Piotrowska (Supported by Jeffrey S. Kahn) 
Section of Pediatric Infectious Diseases 
Yale University School of Medicine, New Haven, CT 
 
Human rhinoviruses (HRV) are a common cause of the common cold, and are thought to 
be associated with asthma exacerbations in both children and adults. Recently, HRV have been 
identified as a major cause of hospitalization in children < 5 years old. The purpose of this study 
was too determine whether HRV are a cause of either wheezing and/or hospitalization in children 
< 2 years old. 
We used a PCR assay to screen for HRV infection in children < 2 years old: 1) with 
symptoms of upper or lower respiratory tract disease without wheezing; 2) with wheezing; 3) who 
were asymptomatic. A group of children who had a respiratory specimen submitted to a 
diagnostic laboratory for whatever reason and who tested negative for four common viruses in the 
clinical lab were also screened. All specimens were collected between January 1 and December 
31, 2004. Phylogenetic analyses were performed on a majority of HRV isolates.  
Overall, 28 (17%) of 165 children with symptoms of respiratory traction infection without 
wheezing; 21 (26.3%) of 80 children with symptoms of respiratory tract infection and wheezing; 3 
(3%) of 93 asymptomatic children and 47 (23.3%) of 202 children with specimens submitted to 
the diagnostic laboratory tested positive for HRV. The difference between the rate of infection in 
the asymptomatic group and each of the three other groups was statistically significant (p<0.01). 
Among children with samples submitted to the diagnostic laboratory in whom HRV was the only 
identified pathogen, 55% were hospitalized. This rate was similar to that observed for respiratory 
syncytial virus (52.7%) among children of a similar age group and time period (P=0.85). Diverse 
groups of HRV were circulating during the one-year study period. 
We conclude that HRV are important pathogens among young children < 2 years old and 
are responsible for a significant proportion of wheezing this age group. Among a group of children 
with a respiratory specimen submitted to the diagnostic laboratory in whom a rhinovirus was the 
only identified pathogen, a majority were hospitalized.  
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I. BACKGROUND 
 
Clinical significance of respiratory viruses 
 
 Viruses are an important cause of human disease worldwide. In particular, 
viral respiratory tract infections are a major cause of illness in both the adult and 
pediatric populations. Respiratory infections of viral etiology are particularly 
prevalent among children and are a major cause of emergency room visits, 
hospitalizations and significant medical costs in this population.  In 1991, one 
study estimated that parainfluenza virus infections in children lead to 250,000 
emergency room visits, 70,000 hospitalizations and $190 million in medical costs 
annually1. Likewise, approximately 100,000 children are hospitalized annually 
due to respiratory syncytial virus (RSV) infection, resulting in an annual cost of 
$300 million2, 3. 
 Although they are common among all age groups, viral respiratory tract 
infections are particularly prevalent among young children. In a report from the 
New Vaccine Surveillance Network, the rate of hospital admissions for acute 
respiratory illness in children less than 5 years old was reported to be 180 per 
10,000 children, and a respiratory virus was identified in 61% of these 
hospitalizations (approximately 110 per 10,000 children)4.  To compare the rates 
of viral infection among children and adults, Hammond et al looked at the 
percentage of lower respiratory tract disease which could be attributed to a viral 
pathogen among patients of different ages5. In infants, viruses are responsible 
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for up to 90% of cases of pneumonia. In children age 2 to 5 years 58% of lower 
respiratory tract infections are viral, whereas in children older than 5 years viral 
pathogens account for 37% of lower respiratory tract disease. In the adult 
population, this percentage is much lower-- only 12% of lower respiratory tract 
infections are associated with a viral etiology5.  Although adults frequently suffer 
from mild viral infections of the upper respiratory tract, virus-associated 
pneumonias are relatively uncommon in this population. It is postulated that the 
relative immaturity of the infant immune system and a lack of adaptive immunity 
may lead to increased susceptibility to viral infections among our youngest 
patients5.  
 Although the majority of viral respiratory tract infections cause disease of 
mild to moderate severity, viruses can also be a significant cause of morbidity, 
and even mortality. Among children, one fifth of the five million deaths due to 
respiratory tract disease reported annually are associated with a viral infection6. 
The mortality of viral illness is even higher among children in the developing 
world, where it is estimated that 4-5 million children die of acute respiratory 
infections each year, with viruses accounting for over half of these deaths7, 8. 
 
A wide variety of viruses infect the human respiratory tract 
 
There are over 200 viruses known to infect the respiratory tract, 
representing a variety of viral families. Many of these pathogens were discovered 
during a boom in the study of virology that occurred during the 1950s and 1960s. 
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Prior to that time, the influenza viruses were the only known, filterable respiratory 
viruses. The first influenza A virus was discovered in swine in 1931, and the first 
human isolates of influenza A were identified two years later.9 The B and C 
strains of influenza were discovered in 1940 and 1947, respectively. In 1953 
Rowe, Huebner and Hilleman identified the first adenovirus and established its 
significance in acute febrile respiratory tract disease10, 11. These discoveries 
paved the way for the identification of other important respiratory viruses during 
this decade, including the parainfluenza viruses, which were first isolated from 
children with croup in 1954 and 195812. In 1954, Morris et al identified a 
chimpanzee coryza agent, which was subsequently linked to isolates identified in 
infants with bronchopneumonia and laryngotracheobronchitis, leading to the 
identification of RSV in 195713, 14. In the same year, the first human rhinovirus 
was isolated from the nasal washings of naval recruits with mild cold-like 
symptoms15.  
Many of the viruses discovered during this time are now known to 
represent the most common respiratory pathogens. For example, influenza virus 
is the most commonly-isolated viral respiratory pathogen among adults. Among 
children, RSV causes the majority of clinically-significant viral infections of the 
respiratory tract. In particular, RSV represents 24-36% of community-acquired 
pneumonia in children, which can also be associated with parainfluenza virus 1, 
2 and 3, human metapneumovirus (hMPV), influenza virus and adenovirus5. The 
human rhinoviruses are the most common agents associated with the common 
cold, and are known to cause up to 80% of cases of mild upper respiratory tract 
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infections. The HRV are also associated with otitis media, sinusitis and, in 
particular, with asthma exacerbations in both children and adults. 
 
Epidemiology of respiratory viruses 
 
 The respiratory tract is a major portal of entry for human pathogens, 
making viral respiratory tract infections extremely common around the world. By 
definition, respiratory viruses are transmitted by airborne droplets. An infected 
human or animal host can shed viral particles by any mechanism which spreads 
respiratory secretions, including coughing, sneezing, or talking. Sneezing, in 
particular, disperses up to a million tiny aerosolized virus-filled droplets less than 
10µm in diameter6. Due to their small size, these droplets can remain suspended 
in the air for minutes and be transmitted by inhalation to others in the vicinity. 
Coughing, spitting and speaking, on the other hand, produce larger droplets 
(>100 µm) which fall to the ground more rapidly, affecting only those in close 
proximity immediately after they are released. Viral particles can also be 
transmitted directly by passing oral and nasal secretions via hands or other direct 
contact to another person’s nose or mouth. 
 While viral respiratory tract infections are common throughout the year, a 
seasonal distribution of the “common cold” has been described. In particular, 
rhinovirus-associated infections have been noted to peak in spring and fall 
months16. Interestingly, Johnston et al noted an increase in HRV infection during 
the academic school year, with decreased rates of infection during times of 
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school rescess17. The association between viral infections and school attendance 
suggests that such small, enclosed environments facilitate the transmission of 
respiratory viruses through aerosolized particles or hand-mouth contact. This is 
also supported by outbreaks of respiratory tract infections which are so 
commonly seen in other closed communities such as long-term care facilities18.  
Respiratory viruses, in particular, are likely to be spread by close contact 
because large numbers of viral particles, 103-109 particles per ml of respiratory 
secretions, are shed during the peak of infection6. In general, this peak infectivity 
coincides with the period during which the patient is most likely to be sneezing 
and coughing frequently, readily spreading contaminated respiratory secretions. 
Furthermore, respiratory viruses are highly infectious; even a single viral particle 
may be enough to initiate a respiratory tract infection. In this way, respiratory 
viruses can spread easily and rapidly across populations, leading to frequent 
outbreaks of respiratory tract infections. 
 
Mechanisms of viral pathogenesis in the respiratory tract 
 
 Once inhaled, viral particles settle at different locations within the 
respiratory tract depending on particle size. Large droplets (those >10µm in 
diameter) may be deposited in the nasal turbinates while smaller particles may 
travel to the lower respiratory tract and be trapped in the trachea or bronchioles. 
Infection is initiated when a virion attaches to a susceptible epithelial cell via 
appropriate ligand-receptor interactions. The virus then enters the cell, replicates, 
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and, several hours later, may be released from the apical surface of the cell into 
the lumen of the respiratory tract. Human defense mechanisms against viral 
infection include alveolar macrophages, which phagocytose and inactivate the 
viral particles before infection occurs. A thick layer of mucus lining the respiratory 
tract traps viral particles leading them to be swallowed or expelled by coughing. 
The mucus layer also contains virus-inactivating substances such as glycoprotein 
inhibitors which neutralize influenza, while lung surfactant contains mannose-
binding lectins which also have anti-viral activity. Finally, virus-infected epithelial 
cells may produce and secrete interferon, which binds to interferon receptors on 
neighboring cells, thereby protecting them from viral infection6. 
 In cases of re-infection, when pre-formed virus-specific antibodies are 
already present in the respiratory tract, these antibodies bind to viral antigens, 
blocking the pathogen’s ability to bind to and infect epithelial cells. In cases of 
primary infection, viral infection may continue, relatively unhindered, for several 
days before a humoral response is mounted. During this lag time, non-specific 
immune mechanisms such as natural killer (NK) cells are activated by interferon 
and act to lyse cells infected with virus. Shortly thereafter, T-lymphocytes are 
recruited and trigger lymphokines to stimulate further immune response, 
eventually leading to the production of virus-specific antibodies by B-
lymphocytes. 
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Methods of Viral Detection: 
 
 Most common respiratory pathogens identified during the 1950s and 
1960s were first characterized and studied by propagating the viral particles in 
live cell lines. Such traditional cell culture methods remain an important tool used 
by virology researchers, but they are now complemented by a variety of 
molecular and antibody-based methods used to identify, diagnose and study viral 
pathogens. Each of these methods has significant advantages and 
disadvantages, outlined below. Together, these techniques provide scientists 
with a variety of tools with which to study the epidemiology and molecular 
characteristics of previously-known and newly-discovered viruses. 
 
Cell culture 
 Traditionally, propagation of viral particles in cell culture served as the 
main tool of researchers studying respiratory viruses. The main advantage of 
traditional cell culture methods is the ability to identify a wide variety of viruses 
and detect multiple viruses within a single sample. Furthermore, cell culture 
requires no a priori knowledge of the virus which is being propagated, making it a 
useful diagnostic tool in the clinical setting. By using cell lines of different origins 
and different growth conditions, researchers can propagate a multitude of 
viruses. Viruses which have been shown to propagate in cell culture are 
numerous and include common pathogens such as adenovirus, cytomegalovirus 
(CMV), polioviruses, coxsackieviruses, echoviruses, herpes simplex virus (HSV), 
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influenza A and B viruses, measles virus, mumps virus, parainfluenza virus types 
1 to 4, RSV, rhinoviruses, and varicella-zoster virus (VZV), as well as Ebola 
virus, severe acute respiratory syndrome coronavirus (SARS-CoV) and hMPV19.  
The proliferation of viruses is detected by identifying cytopathic effects 
(CPE) of the viral particles on cells in the culture. CPE can include a variety of 
morphologic changes, including swelling, shrinking, rounding or clustering of 
cells, syncytium formation or even destruction of the monolayer. The degree of 
CPE varies with the viral species being studied; some viruses, such as HSV, 
produce easily-visible CPE within 24 hours of culture inoculation19. Most viruses, 
however, take days to weeks to develop CPE, and the effects they produce can 
be subtle. Thus, the detection of viral propagation in cell culture by identification 
of CPE can be a slow, time-consuming and operator-dependent process. 
Moreover, cell culture can have poor sensitivity in detecting viruses present in 
low titers.  
While these techniques have lead to many important discoveries in the 
field of virology and cell culture remains an important scientific tool, the 
introduction of antibody-based and molecular probe-based methods of viral 
detection are important new tools which have revolutionized the study of viral 
pathogens. 
 
Viral antigen detection and serologic assays 
 In techniques such as immunofluorescence (IF), fluorescence-labeled 
antibodies specific to particular viral antigens are used to detect even small 
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amounts of viral particles in cell culture and directly within tissues. Fluorescence-
labeled antibodies were first used as a diagnostic tool in clinical virology in 1956, 
when Liu used these antibodies to detect influenza virus antigen in nasal 
smears20.  In the 1970s, the introduction of monoclonal antibodies allowed 
scientists to create antibodies specific to individual viruses. This development 
revolutionized our ability to detect and study pathogens which had been difficult 
to detect through traditional cell culture methods. In the 1980s, monoclonal 
antibodies were introduced as a diagnostic method and improved our ability to 
detect a variety of viral antigens in the clinical setting. 
Clinically, serologic assays to detect human antibodies to a desired virus 
are an alternative to the direct detection of viral antigens. While serologic assays 
are an important tool in the clinical laboratory, these methods are not without 
their own limitations. First, not all clinically significant viral infections will generate 
a detectable serologic response in the human host. For example, as many as 
30% of culture-positive cases of influenza infection are serologically negative1. 
Moreover, many antibodies may cross-react with viral antigens from multiple 
related viruses; for example, antibodies to the parainfluenza viruses display 
significant cross-reactivity between the different types of parainfluenza, making it 
difficult to distinguish between them21. Finally, serologic assays may not be 
useful in the acute setting, as it may take up to 2-4 weeks for increased serologic 
titers to a particular virus to be detectable. 
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Molecular Methods 
Although cell culture techniques are still considered, by many, to be the 
“gold standard” of viral diagnostics, the introduction of polymerase chain reaction 
(PCR) in 1985, and the subsequent development of other molecular probe-based 
methods of viral detection, have revolutionized the study of viruses. In particular, 
a variety of techniques commonly known as nucleic acid amplification tests 
(NAATs) allow researchers to rapidly and efficiently detect viral particles with a 
high degree of sensitivity. These methods also avoid the need for highly-
experienced observers to detect subtle effects of CPE. Perhaps most 
importantly, unlike cell culture, the detection of virus by NAAT does not require 
viable viral particles. Finally, NAAT techniques can detect viral particles even 
before viral antigens are present in sufficient quantities to be detected by 
immunofluorescence techniques. A variety of techniques can be classified in the 
NAAT category, including polymerase chain reaction (PCR), reverse-
transcriptase polymerase chain reaction (RT-PCR,) the nucleic acid sequence-
based amplification (NASBA), real-time PCR techniques where amplification and 
detection occur simultaneously, and many others. 
 Most authors agree that molecular diagnostic assays are rapidly becoming 
the new gold standard in virus detection. Their sensitivity is unparalleled, 
reported to be 12-30% higher than cell culture techniques when appropriate 
controls are included to ensure the validity of the assay22. PCR-based techniques 
utilize short oligonucleotide primers that specifically target known segments of 
DNA within a desired viral genome. These sequence serve as the basis for 
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amplification of the desired fragment. PCR-based assays are extremely 
sensitive, capable of detecting even 1 to 10 copies of target DNA23. Moreover, 
PCR amplification is rapid, easy and relatively inexpensive, making it an ideal 
target for the development of new diagnostic tests. By including a reverse 
transcriptase-mediated amplification step, PCR can also be used to detect RNA 
viruses via RT-PCR.  
Multiplex PCR includes primers targeting nucleic acid sequences of 
multiple viruses and allows for the detection of several viruses within a single 
PCR reaction. Recently, researchers have been working to develop 
commercially-available multiplex PCR kits for use in the clinical virology 
laboratory. For example, the Hexaplex PCR kit is capable of detecting seven of 
the most common respiratory viruses—RSV A and B, influenza A and B, hPIV1, 
2 and 3—with 100% sensitivity and 98% specificity.24  
Finally, PCR and RT-PCR-based assays allow researchers to determine 
the nucleic acid sequence of amplified nucleic acid fragments. This sequence 
data can then be used to perform phylogenetic analyses of viral isolates and to 
determine their molecular epidemiology. In this study, RT-PCR screening for the 
human rhinoviruses and sequencing of amplified fragments will be used to 
determine the molecular epidemiology of the HRV circulating in New Haven, 
Connecticut during 2004. 
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The Human Rhinoviruses 
 
As previously mentioned, the human rhinoviruses have long been known 
to be the primary pathogen responsible for mild upper respiratory tract infections 
known as the “common cold.” Recent studies suggest that rhinoviruses are 
responsible for up to 80% of cold cases 25. The majority of common cold cases 
are brief and mild in nature; the median duration of illness is seven days, with 
symptoms usually peaking 1-3 days after onset of infection, persisting for 2-3 
days and then gradually improving26. Symptoms generally associated with HRV 
infection are mild and may include sneezing, nasal obstruction and/or discharge, 
sore throat, headache, cough and malaise. The physical exam is usually normal, 
with the exception of nasal congestion. Laboratory studies may show mild 
neutrophilia and leukopenia on the first day of illness27, but these values typically 
normalize within 1-2 days and thus are unlikely to be detected during routine 
medical visits. In addition to the common cold, HRV are also associated with 
otitis media and sinusitis in children, as well as with more serious infections of 
the upper and lower respiratory tract 28, 29. 
The first HRV was isolated in 1957 by exposing rhesus monkey kidney 
tissue cultures to nasal washings from persons with colds15. The genus name 
was suggested in 1960, and was based upon the location of primary infection in 
the upper respiratory tract. A variety of culture conditions and cell lines quickly 
permitted researchers to appreciate the vast variety of rhinovirus serotypes in 
circulation and within seven years of the initial characterization of rhinoviruses 
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over 30 serotypes had been identified30. To date, over 100 genotypically and 
serotypically diverse HRV are known to be circulating throughout the world. 
Moreover, new HRV continue to be discovered 31, suggesting that this genus may 
be even more diverse than previously thought. 
Despite the large diversity of known HRV serotypes, recent work has 
demonstrated that many of these viruses share common means of entry into the 
host cell. As a result, some researchers divide the rhinoviruses into major and 
minor groups based on cellular receptor usage32. The major group, comprising 
about 90% of known HRV serotypes, is known to enter cells via the intercellular 
adhesion molecule-1 (ICAM-1) receptor33. However, a small minority, about 10% 
of HRV serotypes, use the low-density lipoprotein (LDL) receptor to enter cells 
and deposit genomic material34. 
The HRV are members of the Picornaviridae virus family. As the name 
suggests, members of this family are non-enveloped viruses containing a small 
(pico = small) RNA genome. The single-stranded, positive-sense genome is 
surrounded by a protein shell to create a simple, spherical virion with a diameter 
of about 30nm. In addition to the HRV, this large family contains multiple other 
important human pathogens including hepatitis A virus, poliovirus, as well as 
many human cosxackieviruses, echoviruses and enteroviruses. Among these, 
rhinoviruses are related most closely to the enteroviruses. However, HRV can be 
easily distinguished from other related viruses by their instability in acidic 
conditions (pH values of less than 6.0.) This is in contrast to the enteroviruses, 
hepatoviruses and cardioviruses, whose members are acid stable and retain 
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infectivity at pH values of 3.0 and below35.  This characteristic influences the sites 
of replication of these pathogens. For example, the acid-stable enteroviruses are 
able to pass through the acidic environment of the stomach and retain their 
infectious nature in the intestinal tract. The rhinoviruses, however, cannot 
replicate in the alimentary tract and their primary site of infection is the 
respiratory tract. Moreover, in contrast to enteroviruses, many serotypes of 
rhinovirus are thermostable at temperatures up to 50°C, and can survive for days 
exposed to the environment at ambient temperatures of 24 to 36°C26.   
The single-stranded, positive-sense RNA genome of the Picornaviridae is 
translated immediately upon entry into the cell to produce all the proteins 
required for viral replication. The size of the genome varies in length among the 
Picornaviridae, ranging from 7,209 to 8,450 bases. The length of the HRV 
genome is among the shortest of the family, about 7,200 nucleotides. Like other 
members of the family, the HRV genome contains a single open reading frame 
(ORF) that is translated into one long polyprotein and subsequently processed 
into mature proteins by virus specific proteases. The HRV genome (see figure 
1A) contains four structural proteins, VP1-4. The structure of the human 
rhinovirus is very simple, with an icosahedral capsid composed of 60 identical 
subunits arranged into 12 pentamers (see figure 1C). The four structural proteins 
VP1-4, make up each subunit (see figure 1D), with the VP1, 2 and 3 proteins on 
the capsid surface and the VP4 protein closely associated with the viral RNA 
genome on the inner surface of the capsid. Accordingly, VP1-3 are antigenic and 
are known to be the part of the genome with the highest variability36. 
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In addition, all picornaviridae contain a 5’-untranslated region (5’-UTR) 
which contains sequences that control genome replication and translation, 
including a complex structure known as the internal ribosome entry site (IRES), 
which can bind ribosomal subunits directly. The 5’-UTR of the HRV is about 620 
basepairs in length and is highly conserved among the different HRV serotypes, 
with about 90% sequence homology between any two HRVs37. Regions of the 5’-
UTR have been used to design molecular probes capable of detecting multiple 
rhinovirus serotypes within a single assay. Oligonucleotide PCR primers 
targeting the 5’UTR of HRV were used in this study. 
  
The role of rhinoviruses in asthma exacerbation 
 
In addition to their role as a major cause of the common cold, HRV have 
also been implicated in exacerbations of asthma among both adults 38 and 
children 39. In their study of children seen in the emergency department with 
wheezing, Duff et al demonstrated that in young children (those younger than 2 
years) the major risk factors for acute wheezing episodes were RSV infection 
and cigarette smoke exposure40. However, for children older than two years, viral 
infections, and in particular HRV infection, were the greatest risk factors for 
wheezing. A history of respiratory allergies was also identified as a risk factor for 
wheezing in older children, suggesting that respiratory allergies and HRV 
infection may have a synergistic effect in increasing the likelihood of wheezing 
episodes40, 41. Furthermore, Johnston et al demonstrated that 80-85% of school-
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aged children with a history of asthma were infected with a virus during wheezing 
episodes, and that the most commonly-isolated virus in this population was 
HRV39. Finally, in adults, about one half of asthma exacerbations can be 
attributed to rhinovirus infection42. However, given the fact that HRV are among 
the most common respiratory viruses, the association between HRV and asthma 
exacerbation merits further investigation. Does the presence of HRV necessarily 
cause disease? While these data suggest that viral infections, particularly HRV 
infections, are associated with the development of asthma exacerbation or 
wheezing in children and adults with pre-existing asthma, few studies have 
compared the rates of infection among wheezing patients to those of 
asymptomatic controls. 
The molecular mechanisms underlying rhinovirus-induced asthma 
exacerbations remain an area of active research. Most researchers agree that 
the pathologic effects of HRV infection occur mainly at the level of the bronchial 
epithelium. Patients with asthma, in particular, are thought to have an especially 
fragile bronchial epithelium which is susceptible to the cytotoxic effects of HRV 
infection. Some studies suggest that the major HRV cell surface receptor 
molecule, ICAM-1, may also play a role in allergic inflammation of the airways43, 
and that HRV may, in fact, act to upregulate ICAM-1 receptors via release of the 
chemokine NF-kappa B44. NF-kappa B also up-regulates other proinflammatory 
cytokines and chemokines. Specifically, HRV infection of airway epithelial cells is 
known to increase levels of interleukins involved in B- and T-cell maturation and 
recruitment of neutrophils. Moreover, HRV infection increases levels of IL-16, an 
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interleukin known to be involved in chemotaxis of eosinophils and monocytes.45 
Finally, airway epithelial cells infected by an HRV are also known to product the 
chemokines eotaxin and RANTES (Regulated upon Activation, 
Normal T-cell Expressed and Secreted), which are both known to be involved in 
the chemotaxis of eosinophils leading to airway inflammation45. 
 In addition to inducing a chemokine profile favoring an allergic, 
proinflammatory response, infection with an HRV is also believed to promote a 
type 2 inflammatory response, characterized by high IL-4 levels. Researchers 
have noted that asthmatic individuals may have a deficient type 1 inflammatory 
response, with low levels of characteristic cytokines such as interferon-gamma 
and low interferon-gamma:IL-4 ratios, which may lead to low antiviral activity and 
a predisposition to HRV infection in these patients46. Therefore, asthmatic 
patients may clear HRV infections more slowly, allowing for the development of 
airway inflammation and, potentially, asthma exacerbation. 
 
The current study 
 
Recently, Miller et al reported an association between HRV infection and 
hospitalization in children < 5 years old 47. While these studies suggest that HRV 
infections are common and are likely the cause of a substantial proportion of 
respiratory tract infections, the prevalence of this pathogen among asymptomatic 
children, for the most part, has not been studied suggesting that the presence of 
HRV does not necessarily cause disease. Therefore the role of these viruses in 
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respiratory tract disease remains poorly defined.  
In order to further investigate the association between HRV and lower 
respiratory tract disease, including wheezing, among young children, we 
screened specimens obtained from children < 2 years old between January and 
December 2004 for HRV and compared these results to results from a group of 
asymptomatic controls whose specimens were obtained during the same year. 
We also screened specimens submitted to a clinical diagnostic laboratory for 
HRV. Lastly, we defined the molecular epidemiology of HRV during a 1 year 
period in New Haven, Connecticut. 
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II. STATEMENT OF PURPOSE 
 
Hypothesis:  
 
Rhinovirus infection is a major cause of wheezing and respiratory illness in young 
children, and rates of rhinovirus infection are significantly higher among sick 
children than among asymptomatic controls. 
 
 
Specific Aims: 
 
1. To define the epidemiology of HRV infection among children < 2 years 
old in New Haven, CT 
2. To determine whether HRV are a cause of wheezing and other 
respiratory tract disease in this population 
3. To determine the molecular epidemiology of HRV strains circulating in 
New Haven, CT in 2004 
4. To determine the clinical characteristics of HRV infection among 
children with HRV-positive respiratory specimens submitted to a 
diagnostic laboratory 
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III. METHODS 
 
Specimens 
 
 Nasopharyngeal aspirates were collected from children < 2 years old 
between January and December 2004. Respiratory specimens from all groups 
were stored at –20OC after addition of an equal volume of “viral freezing media” 
(2X Dulbecco’s modified Eagle medium, 200 mmol/L MgSO4 and 100 mmol/L 
HEPES [pH 7.5]). Study subjects originated from four clinical groups, as 
summarized in table 1. Groups 1-3 were patients identified prospectively in the 
Yale Primary Care Center (PCC). Group 1 included children who had evidence of 
upper and/or lower respiratory tract infection without wheezing (PCC non-
wheezing); Group 2 included children who had evidence of wheezing (PCC 
wheezing); Group 3 included asymptomatic children who were seen for routine 
well-child visits and did not have any evidence of either upper or lower 
respiratory tract infection (Asymptomatic). Group 4 included children from whom 
a respiratory specimen was submitted to the Yale-New Haven Hospital Clinical 
Virology Laboratory (Clinical Virology) for testing for respiratory viruses. 
Specimens from patients in Group 4 were submitted at the discretion of the 
medical team from the Emergency Department, inpatient wards, intensive care 
units and hospital-affiliated outpatient urgent care clinics. Patients were included 
in Group 4 only if the results of the tests on the specimens were negative for 
adenovirus, parainfluenza virus 1-3, influenza A and B and RSV by direct 
 25
immunofluorescence assay (DFA). Furthermore, all specimens from each group 
were screen for the human bocavirus (HBoV) by PCR as previously described 48.  
 
RNA extraction, RT-PCR 
 
RNA was extracted using a commercially-available nucleic acid 
purification kit (Qiagen, Valencia, CA) according to manufacturer’s instructions. 
Reverse transcriptase (RT) was performed using random hexamer primers and 
MuMLV RT (New England Biolabs, Beverly, MA), according to the 
manufacturer’s specifications. PCR amplification was performed using the PICO-
F3 and PICO-R3 primers 49 which amplify a 115-bp region of the picornavirus 5’-
untranslated region (5’-UTR). For sequencing purposes, a larger (394 bp) portion 
of the picornavirus 5’-UTR was amplified using the OL-26 and OL-27 primers 50 
PCR amplification was performed using HotStar Taq polymerase (Qiagen) 
according to the manufacturer’s instructions. PCR amplification cycles were 
performed as follows: 95 OC for 15 min, followed by 40 cycles of 94 OC for 1 min, 
58 OC for 1 min, and 72 OC for 1 min, and completed by a final extension cycle at 
72 OC for 10 minutes. Each set of PCR included appropriate positive and 
negative controls. All primers used in this study were synthesized by the 
Oligonucleotide Laboratory, Department of Pathology, Yale University School of 
Medicine. 
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Sequencing and Phylogenetic Analysis: 
 
All amplicons were sequenced using an Applied Biosystems 3730 XL DNA 
Analyzer at the W. M. Keck Biotechnology Resource Laboratory, Yale University 
School of Medicine. Alignments and phylogenetic analysis were performed using 
Lasergene MegAlign Software (version 5.05; DNAstar) with use of the clustal W 
alignment method. 
 
Clinical data 
 
The clinical data for patients in Groups 1-3 was collected on enrollment. 
The medical records of all HRV-positive children from Group 4 (Clinical Virology) 
were reviewed. Demographic and clinical characteristics were recorded on a 
standardized collection form. Specimen collection and collection of clinical data 
were approved by the Yale University Human Investigation Committee and 
collection of data was compliant with HIPAA regulations. 
 
Statistical analysis 
 
 Fisher’s exact tests were used to determine whether the differences in 
percentage of HRV-positive specimens among different groups were statistically 
significant. 
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IV. RESULTS 
 
Overall, 447 symptomatic children (Groups 1, 2 and 4) and 93 
asymptomatic controls (Group 3) were screened for HRV (Table 2, Figure 2). Of 
the symptomatic children screened, 245 (55%) were seen in the PCC with 
symptoms of respiratory tract disease and 202 (45%) had specimens submitted 
to the Clinical Virology Laboratory. A total of 102 isolates tested positive for a 
picornavirus by initial PCR screening with the PICO-F3 and PICO-R3 primers. 
Three of these isolates were non-HRV and were not included in the analyses 
(see below). 
In all, 28 of 165 children with respiratory symptoms without wheezing 
(17.0%) (Group 1), 21 of 80 children with wheezing (26.3%) (Group 2), 47 of 202 
samples obtained from the Clinical Virology Laboratory (23.3%) (Group 4) and 3  
of 93 asymptomatic children (3.2%) (Group 3) had HRV identified in the sample.  
The differences between each of the three groups of symptomatic children (1, 2, 
4) and the asymptomatic controls (Group 3) were statistically significant (p<0.01). 
The difference in the proportion with HRV between the wheezing (Group 2) and 
non-wheezing (Group 1) children seen at the Primary Care Center (26.3% vs. 
17.0) was not statistically significant (p<0.09). 
The monthly distribution of HRV-positive specimens is shown in figure 3. 
HRV-positive specimens were detected throughout the year with the exception of 
July.  HRV-positive specimens were most frequently identified in the months of 
 28
October-December and April-May. The three cases of asymptomatic HRV-
infection occurred in March and April.  
The distribution of HRV-positive specimens by age is shown in figure 4. All 
children enrolled in the study were < 2 years old. The youngest child from whom 
HRV was identified was 15 days old.  
The clinical features of 40 of the 47 HRV-positive children the children in 
the Clinical Virology group (Group 4) are shown in Table 3. Of the 7 children who 
were not included in the analyses, 2 were co-infected with HBoV and the medical 
records of the remaining 5 patients were not available for review. Overall, 22 
(55%) of 40 of HRV-positive patients in this group were male. The most common 
features observed at or around the time of specimen collection included fever 
(31/40 patients, 77.5%), cough (24/40 patients, 60.0%) and rhinorrhea (24/40 
patients, 60.0%). Wheezing was noted in 19 of 40 (47.2%) patients, and chest 
retractions were observed in 18 of 40 (45%) patients. Only 6 (15.4%) of 39 
patients had a prior documented history of wheezing or of asthma. Of the 25 
patients for whom chest radiographs were obtained, 5 (20%) patients had 
abnormal findings. Abnormalities included hyperinflation, peribronchial cuffing 
and atelectasis. Hypoxia was not a common feature of HRV infection, noted in 
only 6 (15.0%) of 40 patients in this population. Nine of the 40 HRV-positive 
patients had comorbid conditions, which included prematurity, pulmonary 
abnormalities, congenital heart abnormalities and metabolic disorder.  
Of the 40 HRV-positive children in the Clinical Virology Group, 22 (55%) 
were hospitalized.  We compared this rate of hospitalization to that of children 
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infected with another common respiratory virus, RSV. We reviewed the medical 
records of every 4th child < 2 years old who had a respiratory specimen submitted 
to the same diagnostic laboratory during the same study period and who tested 
positive for RSV. Of the 93 children in the RSV-infected group, 49 (52.7%) were 
hospitalized. The percentage of HRV-positive children who were hospitalized 
(55%) and the percentage of RSV-infected children who were hospitalized 
(52.7%) were not statistically significantly different (p=0.85). 
A subset (87 isolates) of the 102 picornavirus-positive specimens was 
sequenced to confirm HRV infection. Among these 87 isolates, 84 (96.6%) had 
sequences that matched known HRV sequences and 3 (3.4%) most closely 
resembled non-HRV picornaviruses: the sequence of 2 of these isolates were 
consistent with a human Coxsackie virus and the sequence of one isolate 
resembled a human enterovirus.  As stated above, these 3 specimens were 
excluded. Of the 15 picornavirus-positive specimens which were not sequenced, 
it is likely that 3.4%, or about (less than) one isolate, was a non-HRV 
picornavirus. Therefore, these 15 specimens were considered to represent HRV 
infection and were included in further analyses. While it is possible, albeit 
unlikely, that one or more of these 15 isolates were non-HRV, we performed the 
statistical analyses with these 15 isolates omitted from the data set (data not 
shown). The results of statistical comparisons were unchanged.  
Phylogenetic analysis of HRV-positive specimens indicated that a wide 
variety of HRV genotypes circulated in New Haven throughout 2004 (figure 5). 
The data suggests that as many as eleven different genotypes of HRV may have 
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been circulating in Connecticut during the study period. Some identified 
sequences showed close identity to previously described HRV serotypes and 
genotypes, though some of the identified sequences showed as little as 82% 
identity with previously described HRV strains. No association could be identified 
between particular genotypes and either specific clinical  groups or clinical 
features within children from Group 4. Specifically, genotypes were not clustered 
among patients from the wheezing group or among patients with clinical features 
of wheezing in the clinical virology group. Likewise, there appears to be no 
association between particular genotypes and the month or season of specimen 
collection (data not shown). 
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V. DISCUSSION 
 
We found a high rate of HRV infection (17-26%) among sick children in 
New Haven, CT compared with asymptomatic control patients (3%). The data 
support recent findings that HRV are a major cause of morbidity among young 
children and suggest that the detection of these viruses does not simply 
represent asymptomatic infection. 
We detected HRV in the respiratory specimens of 22.3% of children who 
had samples submitted to the Clinical Virology laboratory and who were negative 
for RSV, parainfluenza virus 1-3, influenza A and B, adenovirus and HBoV. This 
rate of infection is higher than the 8% rate of human metapneumovirus (hMPV) 
infection previously detected in a similar population in New Haven 51. Other 
researchers have found HRV to have a prevalence of 26% in sick children, 
higher than the prevalence RSV, influenza, parainfluenza and enteroviruses 47. 
This study and ours strongly suggest that HRV may be a more common 
pathogen than other viruses traditionally associated with lower respiratory tract 
infection.  
Furthermore, 55% of children with specimens submitted to the Clinical 
Virology laboratory who were infected only with an HRV were hospitalized at the 
time of specimen collection. This suggests that HRV infection may be a major 
cause of hospitalization among young children. Indeed, the percentage of HRV-
infected children who were hospitalized was not significantly different from the 
percentage of comparable RSV-infected children who were hospitalized. The 
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high prevalence of HRV, along with considerable morbidity as evidenced by high 
rates of hospitalizations, suggests that these viruses are of major clinical 
significance and that a rapid sensitive assay capable of detecting most rhinovirus 
strains may be an important diagnostic tool.  
Our study suggests that only a small percentage (3.3%) of isolates 
detected using picornavirus-specific primers represent non-rhinovirus 
picornavirus infection. In this study, we detected two cases of infection with 
Coxsackie virus and one case of enterovirus infection. Likewise, Miller et al 
identified enterovirus infection in 2% of their study population 47. These data 
confirm that, within the picornavirus family, HRV are overwhelmingly the most 
common pathogen of the respiratory tract in young children with respiratory 
symptoms.  
Few other studies have included sequence data and phylogenetic 
analyses of HRV strains. Our phylogenetic analysis confirms the broad genetic 
diversity of HRV circulating in Connecticut over a one-year period. These viruses 
show a large number of nucleotide polymorphisms, suggesting that our current 
understanding of the diversity within this genus may underestimate the true 
genetic diversity of HRV strains in circulation. 
Based on our data, no particular HRV strains are more likely to cause 
wheezing and asthma exacerbation than others. Likewise, it does not appear that 
certain isolates are more likely to cause severe disease and hospitalization than 
others at least among those found in 2004. The previously-described seasonality 
of HRV infection, with peaks in spring and fall months16, is not supported by our 
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phylogenetic analysis. There appears to be no association between particular 
isolates and the seasonal distribution of this virus. While most cases of HRV 
infection occurred during spring and fall-winter months, there does not appear to 
have been any specific HRV isolates with peak activity during this period, 
suggesting that these viruses do not have a true seasonal distribution. 
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VI. CONCLUSIONS 
 
We conclude that HRV are important pathogens among young children. 
The clinical significance of HRV infection may have previously been 
underestimated, as HRV appear to be more prevalent than other common 
respiratory viruses, such as hMPV, in children seeking medical care. Rapid 
diagnostic assays with a high degree of sensitivity for detecting this genotypically 
diverse group of viruses may prove to have an important role in the diagnosis of 
respiratory tract infection and of the cause of asthma exacerbations among 
young children. 
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VII. FIGURES 
 
 
 
 
 
Figure 1,  General structure of the rhiovirus genome and capsid.  
A, Schematic representation of the rhinovirus genome. B, 3-dimensional 
computer-enhanced electron micrography of HRV14. C, Icosahedral symmetry of 
rhinovirus capsid. D, Arrangement of rhinovirus structural proteins VP1-3 on 
capsid surface.  
Adapted from Papadopoulos, NG and Johnston, SL. 2000. Rhinoviruses. In 
Principles and Practice of Clinical Virology. AJ Zuckerman, JE Banatavala and 
JR Pattison, editors. John Wiley & Sons. 329-343. 
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Figure 2, Results of RT-PCR screening for HRV by group.  
Percent of HRV(+) specimens in each group is indicated. P-values versus 
asymptomatic control are indicated for each group. Chi-square test was used for 
each pair-wise comparison. 
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Figure 3,  Monthly distribution of HRV(+) specimens.  
The total number of HRV(+) specimens per month is indicated. The breakdown 
by group is indicated for each month. 
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Figure 4,  Distribution of HRV(+) individuals by age at time of specimen 
collection.  
All patients screened were < 2 years old. The total number of positive specimens 
is indicated for each age group. The breakdown of each bar by study group is 
indicated. 
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Figure 5,  Phylogenetic analysis of HRV isolates.  
A 394 bp fragment of the 5’ untranslated region of the HRV genome was 
amplified for sequence analysis. The phylogenetic tree was constructed using 
sequence data from New Haven isolates in conjunction with reference 
sequences obtained from GenBank (reference strains denoted by an asterisk, *) 
Reference strains are identified by GenBank accession number and strain name. 
New Haven isolates are identified by Kahn lab ID number. 
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VIII. TABLES 
 
Table 1: Study Groups 
3 Asymptomatic Children < 2 years old visiting the Yale 
Primary Care Center (PCC) for routine well-
child visits with no evidence of respiratory 
tract disease 
 
Group  Name  Description 
1 Non-Wheezing (PCC) Children < 2 years old evaluated in the PCC 
with evidence of upper/lower respiratory tract 
infection without wheezing. 
2 Wheezing (PCC) Children < 2 years old evaluated in the PCC 
with evidence of upper/lower respiratory tract 
infection including wheezing. 
4 Clinical Virology Children < 2 years old who had specimens 
submitted to the Clinical Virology Laboratory 
that tested negative for RSV, influenza A and 
B, human parainfluenza viruses 1-3 and 
adenoviruses 
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Table 2: Screening of children < 2 years of age for HRV, by Group 
 
Group Name  HRV-positive specimens/ 
Total no. of specimens screened (%) 
1 Non-Wheezing (PCC) 28/165 (17.0) 
2 Wheezing (PCC) 21/80 (26.3) 
3 Asymptomatic 3/93 (3.2) 
4 Clinical Virology 47/202 (23.3) 
 
Table 3: Clinical features of HRV infection in the Clinical Virology group 
 
Clinical Feature Patients, no. (%)(a) 
Fever(b) 31 (77.5) 
Cough 24 (60.0) 
Rhinorrhea 24 (60.0) 
Wheezing 19 (47.5) 
Retractions 18 (45.0) 
Prior hx wheeze/asthma 6 (15.0) 
Hypoxia(c) 6 (15.0) 
Abnormal CXR (n=25)(d) 5 (20.0) 
Comorbidity(e) 9 (22.5) 
Hospitalized 22 (55.0) 
Male 22 (55.0) 
 
a. Percent of total (40 patients) b. Temperature > 38.0°C (Range 38.0°C-40.3°C, 
mean 38.7°C). c. O2 sat <90%. d. Chest X-Ray abnormalities included 
hyperinflation, infiltrates, peribronchial cuffing and atelectasis. e. Comorbidities 
included prematurity, pulmonary abnormalities (hypoplastic left lung, primary 
pulmonary hypertension, bronchopulmonary dysplasia) tracheostomy, congenital 
heart abnormalities (double aortic arch, aortic stenosis, patent foramen ovale, 
patent ductus arteriosis), DiGeorge syndrome, Very Long Chain Acyl CoA 
Dehydrogenase Deficiency, and anoxic brain injury/seizure disorder. 
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